Stephen H. Willard

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Wilmington, DE
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul T. Lehr, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Stephen H. Willard

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

NRX Pharmaceuticals, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
50,000
Estimated value
$15,995
Report date
16 Dec 2022
Price
$0.3199
Ownership
Direct
Form 4 holding Chief Executive Officer

Longeveron Inc.

Security class
Stock Option (right to buy)
Shares / value
200,000
Estimated value
Report date
02 Mar 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Stephen H. Willard

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .